Zobrazeno 1 - 8
of 8
pro vyhledávání: '"William B. Tabayoyong"'
Publikováno v:
Cancer. 129:39-48
Improving clinical trial design is important for optimizing approval of safe and effective drugs. Phase 1 clinical trials seek to determine phase 2 doses by investigating predefined dose-limiting toxicities. Traditional definitions of dose-limiting t
Publikováno v:
Transplantation. 86:1803-1809
Induction of transplantation tolerance remains a major challenge in solid organ transplantation. Virtually all transplant recipients require life-long immunosuppression, which is associated with substantial risks including opportunistic infection, ca
Publikováno v:
Leukemia Research. 31:121-125
The goal of this editorial is to revisit soluble human leukocyte antigens (sHLA) and to highlight the findings reported by Albitar et al. in this issue on the relation between sHLA levels in Non-Hodgkin's Lymphoma (NHL) and Hodgkin's Disease (HD). We
Publikováno v:
The Journal of Immunology. 169:3485-3491
TGF-β regulation of immune homeostasis has been investigated in the context of cytokine knockout (TGF-β null) mice, in which particular TGF-β isoforms are disrupted throughout the entire organism, as well as in B and T cell-specific transgenic mod
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 183(9)
Embryonic stem (ES) cells are a novel source of cells, especially hematopoietic progenitor cells that can be used to treat degenerative diseases in humans. However, there is a need to determine how ES cell-derived progenitors are regulated by both th
Publikováno v:
Cell research. 19(4)
Since the derivation of embryonic stem (ES) cell lines from human blastocysts in 1998 1, ES cells have emerged as a potential source of cells and tissues that could be used for cell replacement therapy of incurable degenerative diseases. This is due
Publikováno v:
The FASEB Journal. 23
Publikováno v:
Transplantation. 86:107